The global spatial genomics and transcriptomics market is witnessing rapid growth, driven by increasing investments from government bodies, private organizations, and strategic collaborations between biotech companies and academic institutions. As funding in spatial transcriptomics continues to surge, the adoption of spatial analysis techniques is accelerating across research and clinical settings. This momentum is paving the way for groundbreaking advancements in spatial gene expression analysis, positioning the field at the forefront of precision medicine.
Key growth drivers of Spatial Genomics and Transcriptomics Market include rising demand for spatial omics in drug discovery, advancements in sequencing technologies, and increasing use of high-resolution single-cell analysis for tackling complex diseases like cancer and neurological disorders.
According to BIS research, the global spatial genomics and transcriptomics market is projected to grow from $662.3 million in 2024 to $2,158.6 million by 2034, at a CAGR of 12.54%. This surge highlights the market’s critical role in advancing precision medicine and AI-driven biomedical research.
Need more details on Market Growth and Competitors Download Sample Report
Segmentation 1: Based on Product Type
• Kits and Assays
• Instrument
• Software
• Services
Segmentation 2: Based on Sample Type
• Fresh Frozen Tissues
• Fixed Frozen Tissues
• Formalin Fixed Paraffin Embedded (FFPE) Tissues
• Cultured Cells
Segmentation 3: Based on Workflow
• Spatial Imaging
• Spatial Sequencing
• Spatial Analysis
Segmentation 4: Based on Application
• Diagnostics
• Translation Research
• Drug Discovery and Development
• Single Cell Analysis
• Cell Biology
Segmentation 5: Based on End User
• Academic Institutes and Research Institutes
• Biopharmaceutical and Biotechnology Companies
• Contract Research Organization
• Others
Segmentation 6: Based on Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
Access Market Insights on Spatial Genomics and Transcriptomics Market
In 2024, the spatial genomics field saw major advancements. Illumina acquired Fluent BioSciences to enhance its single cell multiomics capabilities with simplified, cost-effective technology. 10x Genomics expanded its Xenium platform with a 5,000-plex gene panel, boosting in situ gene analysis. Meanwhile, Akoya Biosciences partnered with Thermo Fisher Scientific to deliver an advanced spatial multiomics workflow, integrating RNA and protein imaging. These developments underscore the growing impact of AI-driven, scalable solutions in spatial biology and precision medicine.
Discover what’s inside Download Complete TOC Now!
According to Swati Sood, Principal Analyst at BIS Research, the spatial genomics and transcriptomics market is poised for strong growth, driven by rising adoption in drug discovery and rapid technological advancements. Enhanced resolution, multiplexing, and multiomics integration are expanding applications in diagnostics and personalized medicine. As these AI-optimized technologies evolve, they are set to become essential tools in data-driven healthcare and precision research.
